Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds

Details for Australian Patent Application No. 2002308909 (hide)

Owner Polarx Biopharmaceuticals, Inc

Inventors Ellison, Ralph M; Mermelstein, Fred H

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002308909

Parent 751932

Filing date 28 November 2002

Wipo publication date 20 March 2003

Acceptance publication date 27 April 2006

International Classifications

A61K 33/36 (2006.01) Medicinal preparations containing inorganic active ingredients - Arsenic

Event Publications

19 December 2002 Complete Application Filed

20 March 2003 Application Open to Public Inspection

  Published as AU-B-2002308909

27 April 2006 Application Accepted

  Published as AU-B-2002308909

24 August 2006 Standard Patent Sealed

13 May 2010 Licence Registered

  Polarx Biopharmaceuticals, Inc ( Phebra Pty Ltd )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002308910-Piston retention system for a fastener driving tool

2002308908-Agitator Mill